Go Pro

Concentrix (CNXC) Financials

Concentrix logo
$22.25 0.00 (0.00%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$22.19 -0.06 (-0.27%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Concentrix

Annual Income Statements for Concentrix

This table shows Concentrix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 11/30/2019 11/30/2020 11/30/2021 11/30/2022 11/30/2023 11/30/2024 11/30/2025
Net Income / (Loss) Attributable to Common Shareholders
117 165 406 435 314 251 -1,279
Consolidated Net Income / (Loss)
117 165 406 436 314 251 -1,279
Net Income / (Loss) Continuing Operations
117 165 406 436 314 251 -1,279
Total Pre-Tax Income
204 268 556 605 408 299 -1,182
Total Operating Income
294 309 572 640 661 596 -918
Total Gross Profit
1,748 1,662 1,969 2,257 2,578 3,449 3,435
Total Revenue
4,708 4,720 5,587 6,324 7,115 9,619 9,826
Operating Revenue
4,708 4,720 5,587 6,324 7,115 9,619 9,826
Total Cost of Revenue
2,959 3,058 3,618 4,067 4,537 6,170 6,391
Operating Cost of Revenue
2,959 3,058 3,618 4,067 4,537 6,170 6,391
Total Operating Expenses
1,454 1,353 1,397 1,617 1,917 2,853 4,353
Selling, General & Admin Expense
1,454 1,353 1,397 1,617 1,917 2,853 2,825
Impairment Charge
- - - - 0.00 0.00 1,528
Total Other Income / (Expense), net
-90 -41 -17 -35 -253 -297 -264
Interest Expense
92 48 23 70 201 322 290
Other Income / (Expense), net
2.28 7.45 6.35 35 -52 25 26
Income Tax Expense
87 103 150 169 94 48 97
Basic Earnings per Share
$2.27 $3.19 $7.78 $8.34 $5.72 $3.72 ($20.36)
Weighted Average Basic Shares Outstanding
51.60M 51.60M 51.36M 51.35M 53.80M 64.98M 63.01M
Diluted Earnings per Share
$2.27 $3.19 $7.70 $8.28 $5.70 $3.71 ($20.36)
Weighted Average Diluted Shares Outstanding
51.60M 51.60M 51.91M 51.74M 54.01M 65.07M 63.01M
Weighted Average Basic & Diluted Shares Outstanding
- - 52.32M 52.07M 66.33M 64.40M 61.60M

Quarterly Income Statements for Concentrix

This table shows Concentrix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026
Net Income / (Loss) Attributable to Common Shareholders
69 52 67 17 116 70 42 88 -1,479 22 55
Consolidated Net Income / (Loss)
69 52 67 17 116 70 42 88 -1,479 22 55
Net Income / (Loss) Continuing Operations
69 52 67 17 116 70 42 88 -1,479 22 55
Total Pre-Tax Income
77 73 87 26 113 101 52 111 -1,446 29 69
Total Operating Income
180 148 150 153 145 169 148 147 -1,382 119 95
Total Gross Profit
823 857 858 864 871 856 848 855 876 850 823
Total Revenue
2,231 2,403 2,381 2,387 2,448 2,372 2,417 2,483 2,553 2,500 2,462
Operating Revenue
2,231 2,403 2,381 2,387 2,448 2,372 2,417 2,483 2,553 2,500 2,462
Total Cost of Revenue
1,408 1,546 1,523 1,523 1,577 1,516 1,569 1,628 1,677 1,651 1,639
Operating Cost of Revenue
1,408 1,546 1,523 1,523 1,577 1,516 1,569 1,628 1,677 1,651 1,639
Total Operating Expenses
642 708 707 711 726 687 700 708 2,258 731 728
Selling, General & Admin Expense
642 708 707 711 726 687 700 708 731 731 728
Total Other Income / (Expense), net
-103 -76 -63 -127 -32 -68 -97 -36 -64 -90 -26
Interest Expense
71 82 82 81 76 73 75 72 70 75 68
Other Income / (Expense), net
-33 6.82 19 -46 44 4.92 -21 36 6.14 -15 42
Income Tax Expense
7.62 21 20 9.79 -2.74 31 9.63 23 33 7.14 14
Basic Earnings per Share
$1.02 $0.76 $0.98 $0.25 $1.73 $1.04 $0.63 $1.34 ($23.37) $0.33 $0.86
Weighted Average Basic Shares Outstanding
53.80M 65.66M 65.27M 64.66M 64.98M 64.04M 63.36M 62.60M 63.01M 61.28M 60.85M
Diluted Earnings per Share
$1.02 $0.76 $0.98 $0.25 $1.72 $1.04 $0.63 $1.34 ($23.37) $0.33 $0.86
Weighted Average Diluted Shares Outstanding
54.01M 65.79M 65.33M 64.75M 65.07M 64.07M 63.41M 62.70M 63.01M 61.30M 60.86M
Weighted Average Basic & Diluted Shares Outstanding
66.33M 65.99M 65.33M 64.82M 64.40M 63.88M 63.03M 62.26M 61.60M 61.00M 61.02M

Annual Cash Flow Statements for Concentrix

This table details how cash moves in and out of Concentrix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 11/30/2019 11/30/2020 11/30/2021 11/30/2022 11/30/2023 11/30/2024 11/30/2025
Net Change in Cash & Equivalents
138 73 27 -26 359 -87 92
Net Cash From Operating Activities
450 508 514 601 678 667 807
Net Cash From Continuing Operating Activities
448 508 514 601 678 667 807
Net Income / (Loss) Continuing Operations
117 165 406 436 314 251 -1,279
Consolidated Net Income / (Loss)
117 165 406 436 314 251 -1,279
Depreciation Expense
139 129 140 147 173 247 226
Amortization Expense
167 147 139 164 221 484 458
Non-Cash Adjustments To Reconcile Net Income
52 49 21 48 86 117 1,645
Changes in Operating Assets and Liabilities, net
-27 18 -192 -194 -117 -431 -243
Net Cash From Investing Activities
-151 -109 -79 -1,839 -2,109 -244 -250
Net Cash From Continuing Investing Activities
-121 -109 -79 -1,839 -2,109 -244 -250
Purchase of Property, Plant & Equipment
-111 -171 -149 -140 -181 -239 -234
Acquisitions
-9.43 -5.56 -3.28 -1,698 -1,914 -5.50 -16
Other Investing Activities, net
- 68 - - -15 0.00 0.00
Net Cash From Financing Activities
-340 -335 -402 1,238 1,803 -493 -491
Net Cash From Continuing Financing Activities
-192 -335 -402 1,238 1,803 -493 -491
Repayment of Debt
0.00 -1,485 -1,661 -2,514 -2,442 -2,407 -4,288
Repurchase of Common Equity
- 0.00 -25 -123 -64 -136 -169
Payment of Dividends
- 0.00 -13 -53 -63 -84 -90
Issuance of Debt
0.00 1,150 1,316 3,931 4,396 2,197 4,086
Other Financing Activities, net
-192 0.00 -19 -2.89 -23 -63 -32
Effect of Exchange Rate Changes
- 9.66 -7.00 -25 -12 -18 26
Cash Interest Paid
- 0.00 21 68 143 282 300
Cash Income Taxes Paid
- 77 160 144 217 298 270

Quarterly Cash Flow Statements for Concentrix

This table details how cash moves in and out of Concentrix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026
Net Change in Cash & Equivalents
-1,608 -99 -20 44 5.42 46 60 3.35 -17 -106 26
Net Cash From Operating Activities
229 -47 238 192 284 1.41 237 225 344 -83 258
Net Cash From Continuing Operating Activities
229 -47 238 192 284 1.41 237 225 344 -83 258
Net Income / (Loss) Continuing Operations
69 52 67 17 116 70 42 88 -1,479 22 55
Consolidated Net Income / (Loss)
69 52 67 17 116 70 42 88 -1,479 22 55
Depreciation Expense
59 68 61 60 59 55 56 57 58 56 58
Amortization Expense
101 122 129 123 116 112 116 118 112 106 104
Non-Cash Adjustments To Reconcile Net Income
23 24 23 29 36 34 33 28 1,550 42 37
Changes in Operating Assets and Liabilities, net
-23 -313 -41 -36 -42 -269 -10 -66 103 -309 3.98
Net Cash From Investing Activities
-1,994 -61 -60 -63 -61 -51 -56 -65 -78 -51 -31
Net Cash From Continuing Investing Activities
-1,979 -61 -60 -63 -61 -51 -56 -65 -78 -51 -31
Purchase of Property, Plant & Equipment
-65 -56 -60 -63 -60 -51 -56 -65 -63 -54 -48
Net Cash From Financing Activities
166 14 -198 -85 -224 102 -149 -165 -280 19 -194
Net Cash From Continuing Financing Activities
180 14 -198 -85 -224 102 -149 -165 -280 19 -194
Repayment of Debt
-938 -533 -676 -582 -615 -507 -1,352 -626 -1,803 -1,702 -1,052
Payment of Dividends
-21 -21 -20 -20 -23 -22 -22 -22 -23 -23 -23
Issuance of Debt
1,166 628 555 548 466 683 1,263 533 1,608 1,803 888
Other Financing Activities, net
-6.14 -38 -15 8.24 -18 -24 7.28 -8.17 -6.32 -16 -6.66
Effect of Exchange Rate Changes
-9.71 -5.54 -0.43 -0.37 - -6.58 28 8.45 -3.32 9.85 -6.89

Annual Balance Sheets for Concentrix

This table presents Concentrix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 11/30/2020 11/30/2021 11/30/2022 11/30/2023 11/30/2024 11/30/2025
Total Assets
5,178 5,046 6,670 12,492 11,991 10,761
Total Current Assets
1,423 1,543 1,754 2,859 2,842 3,085
Cash & Equivalents
153 182 145 295 241 327
Accounts Receivable
1,081 1,208 1,390 1,889 1,927 1,999
Other Current Assets
189 153 218 674 675 758
Other Current Nonoperating Assets
- - - - - 0.00
Plant, Property, & Equipment, net
452 407 404 749 715 736
Total Noncurrent Assets
3,303 3,096 4,512 8,884 8,434 6,941
Goodwill
1,836 1,814 2,904 5,079 4,987 3,672
Intangible Assets
799 656 986 2,805 2,287 1,960
Noncurrent Deferred & Refundable Income Taxes
47 48 49 72 218 317
Other Noncurrent Operating Assets
620 579 573 929 942 991
Total Liabilities & Shareholders' Equity
5,178 5,046 6,670 12,492 11,991 10,761
Total Liabilities
2,875 2,426 3,974 8,349 7,952 8,017
Total Current Liabilities
1,009 968 1,132 2,074 1,996 2,196
Short-Term Debt
34 0.00 0.00 2.31 2.52 66
Accounts Payable
141 129 161 244 210 245
Accrued Expenses
371 352 395 1,016 977 997
Current Deferred & Payable Income Tax Liabilities
21 34 69 81 100 124
Current Employee Benefit Liabilities
420 453 507 731 707 765
Other Current Nonoperating Liabilities
- - - - - 0.00
Total Noncurrent Liabilities
1,867 1,458 2,842 6,274 5,956 5,820
Long-Term Debt
1,111 802 2,224 4,940 4,733 4,573
Noncurrent Deferred & Payable Income Tax Liabilities
154 109 105 414 313 297
Other Noncurrent Operating Liabilities
602 546 512 921 910 951
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,302 2,620 2,696 4,143 4,040 2,744
Total Preferred & Common Equity
2,302 2,620 2,696 4,143 4,040 2,744
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,302 2,620 2,696 4,143 4,040 2,744
Common Stock
0.00 2,356 2,428 3,583 3,684 3,784
Retained Earnings
0.00 392 774 1,024 1,192 -177
Treasury Stock
0.00 -57 -191 -272 -421 -610
Accumulated Other Comprehensive Income / (Loss)
-3.81 -71 -316 -192 -414 -252

Quarterly Balance Sheets for Concentrix

This table presents Concentrix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 2/28/2023 5/31/2023 8/31/2023 2/29/2024 5/31/2024 8/31/2024 2/28/2025 5/31/2025 8/31/2025 2/28/2026 5/31/2026
Total Assets
6,623 6,560 8,450 12,243 12,079 12,208 11,895 12,396 12,410 10,675 10,513
Total Current Assets
1,748 1,752 3,702 2,782 2,716 2,850 2,961 3,171 3,138 3,041 3,040
Cash & Equivalents
178 153 2,113 235 207 246 308 343 350 223 256
Accounts Receivable
1,382 1,394 1,379 1,928 1,872 1,936 2,015 2,061 2,052 2,038 1,988
Other Current Assets
188 205 210 619 637 668 638 766 735 573 594
Other Current Nonoperating Assets
- - - - - - - - - 208 203
Plant, Property, & Equipment, net
399 394 406 730 728 733 678 711 733 726 710
Total Noncurrent Assets
4,476 4,413 4,341 8,731 8,635 8,625 8,257 8,514 8,539 6,907 6,763
Goodwill
2,905 2,904 2,897 5,031 5,026 5,084 4,936 5,132 5,192 3,696 3,653
Intangible Assets
949 911 873 2,673 2,564 2,483 2,161 2,156 2,079 1,867 1,750
Noncurrent Deferred & Refundable Income Taxes
45 45 48 76 112 115 236 248 282 314 343
Other Noncurrent Operating Assets
577 554 523 951 933 943 924 978 986 1,030 1,017
Total Liabilities & Shareholders' Equity
6,623 6,560 8,450 12,243 12,079 12,208 11,895 12,396 12,410 10,675 10,513
Total Liabilities
3,823 3,706 5,546 8,141 7,995 8,039 7,861 8,117 8,066 7,886 7,812
Total Current Liabilities
994 1,007 1,046 1,783 1,766 1,812 1,792 1,973 2,009 2,575 2,579
Short-Term Debt
0.00 0.00 0.00 2.71 1.59 2.86 0.46 28 38 750 650
Accounts Payable
142 149 138 202 202 211 158 209 222 202 198
Accrued Expenses
393 400 398 924 936 933 920 998 970 737 816
Current Deferred & Payable Income Tax Liabilities
71 41 39 60 39 31 128 82 81 89 85
Current Employee Benefit Liabilities
389 418 470 594 589 635 585 656 699 622 658
Other Current Nonoperating Liabilities
- - - - - - - - - 175 172
Total Noncurrent Liabilities
2,829 2,698 4,500 6,358 6,229 6,227 6,069 6,144 6,057 5,311 5,232
Long-Term Debt
2,220 2,131 3,973 5,034 4,924 4,909 4,901 4,862 4,790 3,995 3,935
Noncurrent Deferred & Payable Income Tax Liabilities
100 77 59 386 386 378 294 311 302 301 286
Other Noncurrent Operating Liabilities
509 490 468 938 919 940 874 971 964 1,015 1,012
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,801 2,854 2,904 4,102 4,083 4,169 4,034 4,279 4,344 2,788 2,701
Total Preferred & Common Equity
2,801 2,854 2,904 4,102 4,083 4,169 4,034 4,279 4,344 2,788 2,701
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,801 2,854 2,904 4,102 4,083 4,169 4,034 4,279 4,344 2,788 2,701
Common Stock
2,447 2,459 2,472 3,606 3,628 3,654 3,712 3,738 3,766 3,814 3,838
Retained Earnings
848 912 976 1,056 1,102 1,099 1,240 1,260 1,326 -179 -147
Treasury Stock
-209 -214 -242 -296 -336 -376 -449 -496 -538 -656 -657
Accumulated Other Comprehensive Income / (Loss)
-286 -303 -302 -264 -310 -208 -468 -223 -209 -191 -333

Annual Metrics And Ratios for Concentrix

This table displays calculated financial ratios and metrics derived from Concentrix's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 11/30/2019 11/30/2020 11/30/2021 11/30/2022 11/30/2023 11/30/2024 11/30/2025
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 0.25% 18.38% 13.20% 12.49% 35.20% 2.15%
EBITDA Growth
0.00% -1.60% 44.67% 15.02% 1.75% 34.74% -115.37%
EBIT Growth
0.00% 6.61% 83.03% 16.65% -9.75% 1.95% -243.60%
NOPAT Growth
0.00% 12.60% 119.93% 10.34% 10.29% -1.53% -228.39%
Net Income Growth
0.00% 40.67% 146.09% 7.41% -27.96% -19.95% -609.09%
EPS Growth
0.00% 40.53% 141.38% 7.53% -31.16% -34.91% -648.79%
Operating Cash Flow Growth
0.00% 12.87% 1.29% 16.83% 12.87% -1.55% 20.90%
Free Cash Flow Firm Growth
0.00% 0.00% 115.21% -327.42% -226.64% 121.55% 10.67%
Invested Capital Growth
0.00% 0.00% -1.65% 47.36% 84.09% -2.90% -17.33%
Revenue Q/Q Growth
0.00% 0.00% 3.06% 2.83% 9.04% 2.31% 1.08%
EBITDA Q/Q Growth
0.00% 0.00% 3.96% 4.44% 3.79% 4.35% -115.27%
EBIT Q/Q Growth
0.00% 0.00% 6.49% 4.97% -6.59% 7.14% -232.44%
NOPAT Q/Q Growth
0.00% 0.00% 16.34% -2.36% 9.06% 1.73% -225.88%
Net Income Q/Q Growth
0.00% 0.00% 17.19% -4.21% -10.15% 22.51% -504.58%
EPS Q/Q Growth
0.00% 0.00% 16.84% -4.06% -14.80% 23.26% -530.44%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 13.97% 9.80% -0.94% 9.00% 8.01%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 4.85% -704.75% 121.13% 59.88%
Invested Capital Q/Q Growth
0.00% 0.00% -1.13% -2.11% 84.50% -3.39% -20.02%
Profitability Metrics
- - - - - - -
Gross Margin
37.14% 35.21% 35.25% 35.69% 36.23% 35.86% 34.96%
EBITDA Margin
12.80% 12.56% 15.35% 15.60% 14.11% 14.06% -2.12%
Operating Margin
6.25% 6.54% 10.25% 10.12% 9.30% 6.20% -9.34%
EBIT Margin
6.30% 6.70% 10.36% 10.67% 8.56% 6.46% -9.08%
Profit (Net Income) Margin
2.49% 3.49% 7.26% 6.89% 4.41% 2.61% -13.02%
Tax Burden Percent
57.32% 61.52% 72.99% 72.01% 76.88% 83.94% 108.18%
Interest Burden Percent
68.92% 84.72% 96.02% 89.62% 67.01% 48.18% 132.56%
Effective Tax Rate
42.68% 38.48% 27.01% 27.99% 23.12% 16.06% 0.00%
Return on Invested Capital (ROIC)
0.00% 11.53% 12.79% 11.50% 7.50% 5.78% -8.25%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 6.46% 11.27% 9.63% 1.71% 0.32% -22.69%
Return on Net Nonoperating Assets (RNNOA)
0.00% 2.79% 3.69% 4.89% 1.68% 0.36% -29.46%
Return on Equity (ROE)
0.00% 14.32% 16.48% 16.39% 9.18% 6.14% -37.70%
Cash Return on Invested Capital (CROIC)
0.00% -188.47% 14.45% -26.79% -51.70% 8.73% 10.73%
Operating Return on Assets (OROA)
0.00% 6.11% 11.32% 11.52% 6.36% 5.07% -7.84%
Return on Assets (ROA)
0.00% 3.18% 7.93% 7.44% 3.28% 2.05% -11.24%
Return on Common Equity (ROCE)
0.00% 14.32% 16.48% 16.39% 9.18% 6.14% -37.70%
Return on Equity Simple (ROE_SIMPLE)
0.00% 7.16% 15.48% 16.16% 7.57% 6.22% 0.00%
Net Operating Profit after Tax (NOPAT)
169 190 418 461 508 501 -643
NOPAT Margin
3.58% 4.02% 7.48% 7.29% 7.15% 5.20% -6.54%
Net Nonoperating Expense Percent (NNEP)
0.00% 5.07% 1.51% 1.88% 5.79% 5.46% 14.45%
Return On Investment Capital (ROIC_SIMPLE)
- - - 9.37% 5.60% 5.70% -8.71%
Cost of Revenue to Revenue
62.86% 64.79% 64.75% 64.31% 63.77% 64.14% 65.04%
SG&A Expenses to Revenue
30.89% 28.66% 25.01% 25.57% 26.94% 29.66% 28.76%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
30.89% 28.66% 25.01% 25.57% 26.94% 29.66% 44.30%
Earnings before Interest and Taxes (EBIT)
297 316 579 675 609 621 -892
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
602 593 858 986 1,004 1,352 -208
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 3.21 2.27 1.48 0.72 0.82
Price to Tangible Book Value (P/TBV)
0.00 0.00 55.60 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 1.50 0.97 0.86 0.30 0.23
Price to Earnings (P/E)
0.00 0.00 20.73 14.07 19.54 11.60 0.00
Dividend Yield
0.00% 0.00% 0.16% 0.87% 1.22% 2.76% 3.75%
Earnings Yield
0.00% 0.00% 4.82% 7.11% 5.12% 8.62% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 2.79 1.72 1.23 0.87 0.93
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 1.62 1.30 1.52 0.77 0.67
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 10.53 8.31 10.74 5.48 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 15.60 12.15 17.69 11.93 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 21.61 17.79 21.20 14.80 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 17.56 13.65 15.90 11.10 8.14
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 19.12 0.00 0.00 9.80 7.85
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.50 0.31 0.83 1.19 1.17 1.69
Long-Term Debt to Equity
0.00 0.48 0.31 0.83 1.19 1.17 1.67
Financial Leverage
0.00 0.43 0.33 0.51 0.98 1.12 1.30
Leverage Ratio
0.00 2.25 2.08 2.20 2.80 2.99 3.35
Compound Leverage Factor
0.00 1.91 1.99 1.98 1.88 1.44 4.45
Debt to Total Capital
0.00% 33.22% 23.44% 45.21% 54.40% 53.96% 62.83%
Short-Term Debt to Total Capital
0.00% 0.98% 0.00% 0.00% 0.03% 0.03% 0.89%
Long-Term Debt to Total Capital
0.00% 32.24% 23.44% 45.21% 54.37% 53.94% 61.94%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 66.78% 76.56% 54.79% 45.60% 46.04% 37.17%
Debt to EBITDA
0.00 1.93 0.94 2.26 4.92 3.50 -22.31
Net Debt to EBITDA
0.00 1.67 0.72 2.11 4.63 3.32 -20.74
Long-Term Debt to EBITDA
0.00 1.87 0.94 2.26 4.92 3.50 -22.00
Debt to NOPAT
0.00 6.03 1.92 4.83 9.72 9.46 -7.22
Net Debt to NOPAT
0.00 5.22 1.48 4.51 9.14 8.98 -6.71
Long-Term Debt to NOPAT
0.00 5.85 1.92 4.83 9.72 9.45 -7.11
Altman Z-Score
0.00 0.00 3.81 2.48 1.36 1.42 0.88
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 1.41 1.59 1.55 1.38 1.42 1.40
Quick Ratio
0.00 1.22 1.44 1.36 1.05 1.09 1.06
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -3,105 472 -1,074 -3,507 756 836
Operating Cash Flow to CapEx
404.72% 296.28% 344.90% 429.03% 375.56% 279.56% 344.13%
Free Cash Flow to Firm to Interest Expense
0.00 -64.26 20.48 -15.32 -17.45 2.35 2.88
Operating Cash Flow to Interest Expense
4.88 10.51 22.31 8.57 3.37 2.07 2.78
Operating Cash Flow Less CapEx to Interest Expense
3.67 6.96 15.84 6.57 2.48 1.33 1.97
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.91 1.09 1.08 0.74 0.79 0.86
Accounts Receivable Turnover
0.00 4.36 4.88 4.87 4.34 5.04 5.01
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 10.45 13.01 15.60 12.35 13.15 13.55
Accounts Payable Turnover
0.00 21.75 26.80 28.00 22.42 27.22 28.12
Days Sales Outstanding (DSO)
0.00 83.64 74.78 74.98 84.12 72.39 72.92
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 16.78 13.62 13.04 16.28 13.41 12.98
Cash Conversion Cycle (CCC)
0.00 66.86 61.17 61.94 67.84 58.98 59.93
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 3,295 3,240 4,775 8,790 8,535 7,056
Invested Capital Turnover
0.00 2.87 1.71 1.58 1.05 1.11 1.26
Increase / (Decrease) in Invested Capital
0.00 3,295 -54 1,535 4,015 -255 -1,479
Enterprise Value (EV)
0.00 0.00 9,028 8,200 10,779 7,409 6,566
Market Capitalization
0.00 0.00 8,408 6,121 6,132 2,914 2,254
Book Value per Share
$0.00 $44.61 $50.08 $52.18 $62.21 $62.32 $44.08
Tangible Book Value per Share
$0.00 ($6.45) $2.89 ($23.11) ($56.16) ($49.90) ($46.38)
Total Capital
0.00 3,447 3,422 4,920 9,085 8,775 7,383
Total Debt
0.00 1,145 802 2,224 4,942 4,736 4,639
Total Long-Term Debt
0.00 1,111 802 2,224 4,940 4,733 4,573
Net Debt
0.00 992 620 2,079 4,647 4,495 4,311
Capital Expenditures (CapEx)
111 171 149 140 181 239 234
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 296 393 477 492 609 626
Debt-free Net Working Capital (DFNWC)
0.00 448 575 622 787 849 954
Net Working Capital (NWC)
0.00 415 575 622 785 847 888
Net Nonoperating Expense (NNE)
52 25 12 25 195 249 636
Net Nonoperating Obligations (NNO)
0.00 992 620 2,079 4,647 4,495 4,311
Total Depreciation and Amortization (D&A)
306 277 279 311 394 731 684
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 6.27% 7.03% 7.54% 6.91% 6.33% 6.38%
Debt-free Net Working Capital to Revenue
0.00% 9.50% 10.29% 9.84% 11.06% 8.83% 9.71%
Net Working Capital to Revenue
0.00% 8.79% 10.29% 9.84% 11.03% 8.80% 9.04%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $7.78 $8.34 $5.72 $3.72 ($20.36)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 51.36M 51.35M 53.80M 64.98M 63.01M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $7.70 $8.28 $5.70 $3.71 ($20.36)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 51.91M 51.74M 54.01M 65.07M 63.01M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 52.32M 52.07M 66.33M 64.40M 61.60M
Normalized Net Operating Profit after Tax (NOPAT)
169 190 418 461 508 501 427
Normalized NOPAT Margin
3.58% 4.02% 7.48% 7.29% 7.15% 5.20% 4.34%
Pre Tax Income Margin
4.34% 5.68% 9.95% 9.57% 5.74% 3.11% -12.03%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
3.22 6.55 25.11 9.63 3.03 1.93 -3.07
NOPAT to Interest Expense
1.83 3.93 18.13 6.58 2.53 1.56 -2.21
EBIT Less CapEx to Interest Expense
2.01 3.00 18.64 7.64 2.13 1.19 -3.88
NOPAT Less CapEx to Interest Expense
0.62 0.39 11.66 4.58 1.63 0.81 -3.02
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 3.23% 12.26% 20.23% 33.36% -7.01%
Augmented Payout Ratio
0.00% 0.00% 9.41% 40.57% 40.61% 87.54% -20.20%

Quarterly Metrics And Ratios for Concentrix

This table displays calculated financial ratios and metrics derived from Concentrix's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026
DEI Shares Outstanding
- - - - - - - - - 61,597,304.00 61,004,826.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 61,597,304.00 61,004,826.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.35 0.91
Growth Metrics
- - - - - - - - - - -
Revenue Growth
35.96% 46.83% 47.44% 46.21% 9.74% -1.27% 1.54% 4.01% 4.29% 5.40% 1.87%
EBITDA Growth
13.55% 50.13% 50.79% 27.04% 18.33% -1.29% -15.45% 23.72% -431.43% -21.89% 0.08%
EBIT Growth
-22.56% 1.92% 10.71% -31.31% 28.05% 11.93% -25.04% 71.09% -828.08% -40.13% 8.20%
NOPAT Growth
41.52% -8.34% -4.77% -18.20% -8.95% 10.84% 4.81% 20.45% -753.61% -24.32% -37.12%
Net Income Growth
-33.79% -40.71% -15.24% -78.58% 66.43% 34.85% -37.02% 429.79% -1,379.19% -69.27% 31.32%
EPS Growth
-49.25% -54.76% -35.10% -83.22% 68.63% 36.84% -35.71% 436.00% -1,458.72% -68.27% 36.51%
Operating Cash Flow Growth
-2.72% -145.11% 78.62% -9.36% 24.05% 103.00% -0.76% 17.32% 21.03% -6,010.51% 9.03%
Free Cash Flow Firm Growth
-171.37% -1,974.06% -2,598.57% -1,815.36% 110.47% 109.95% 102.48% 103.24% 26.84% 265.33% 1,890.37%
Invested Capital Growth
84.09% 83.87% 82.14% 85.43% -2.90% -3.10% 0.29% -0.14% -17.33% -15.64% -20.69%
Revenue Q/Q Growth
36.62% 7.71% -0.92% 0.28% 2.54% -3.10% 1.90% 2.73% 2.81% -2.06% -1.52%
EBITDA Q/Q Growth
34.83% 12.18% 5.90% -19.37% 25.58% -6.41% -12.17% 19.86% -436.42% 122.05% 12.54%
EBIT Q/Q Growth
-5.43% 5.18% 9.22% -36.77% 76.28% -8.06% -26.85% 44.31% -850.17% 107.56% 32.20%
NOPAT Q/Q Growth
37.86% -34.69% 8.47% -16.25% 53.45% -20.49% 2.57% -3.75% -932.70% 109.21% -14.78%
Net Income Q/Q Growth
-10.50% -25.02% 28.28% -75.12% 595.39% -39.25% -40.09% 109.32% -1,779.02% 101.46% 156.04%
EPS Q/Q Growth
-31.54% -25.49% 28.95% -74.49% 588.00% -39.53% -39.42% 112.70% -1,844.03% 101.41% 160.61%
Operating Cash Flow Q/Q Growth
8.44% -120.44% 608.51% -19.60% 48.42% -99.50% 16,699.43% -4.96% 53.12% -124.18% 409.89%
Free Cash Flow Firm Q/Q Growth
-1,763.12% -2.66% 2.56% -3.10% 110.15% -2.38% -75.72% 34.74% 297.19% 181.17% 32.27%
Invested Capital Q/Q Growth
84.50% 1.29% -1.15% 0.37% -3.39% 1.09% 2.31% -0.06% -20.02% 3.16% -3.82%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
36.89% 35.65% 36.02% 36.20% 35.56% 36.08% 35.09% 34.43% 34.31% 33.98% 33.44%
EBITDA Margin
13.78% 14.36% 15.09% 12.14% 14.86% 14.35% 12.37% 14.43% -47.24% 10.64% 12.15%
Operating Margin
8.09% 6.18% 6.31% 6.42% 5.90% 7.12% 6.14% 5.92% -54.15% 4.74% 3.88%
EBIT Margin
6.62% 6.46% 7.12% 4.49% 7.72% 7.33% 5.26% 7.39% -53.91% 4.16% 5.59%
Profit (Net Income) Margin
3.11% 2.17% 2.81% 0.70% 4.72% 2.96% 1.74% 3.55% -57.95% 0.86% 2.24%
Tax Burden Percent
90.11% 71.55% 76.71% 62.96% 102.43% 69.70% 81.38% 79.06% 102.30% 75.14% 79.56%
Interest Burden Percent
52.24% 46.90% 51.38% 24.63% 59.73% 58.00% 40.68% 60.75% 105.08% 27.61% 50.51%
Effective Tax Rate
9.89% 28.45% 23.29% 37.04% -2.43% 30.30% 18.62% 20.94% 0.00% 24.86% 20.44%
Return on Invested Capital (ROIC)
7.65% 5.07% 6.14% 5.59% 6.72% 5.43% 5.45% 5.15% -47.78% 4.46% 3.90%
ROIC Less NNEP Spread (ROIC-NNEP)
4.88% 3.49% 4.69% 3.14% 6.01% 4.42% 3.76% 4.54% -59.40% 2.97% 3.43%
Return on Net Nonoperating Assets (RNNOA)
4.80% 3.46% 4.53% 2.90% 6.71% 5.10% 4.16% 4.87% -77.11% 3.96% 4.35%
Return on Equity (ROE)
12.44% 8.53% 10.67% 8.49% 13.43% 10.53% 9.62% 10.03% -124.88% 8.42% 8.24%
Cash Return on Invested Capital (CROIC)
-51.70% -51.80% -50.95% -52.62% 8.73% 8.94% 5.56% 5.93% 10.73% 8.44% 14.05%
Operating Return on Assets (OROA)
4.91% 5.40% 6.61% 4.09% 6.07% 5.82% 4.14% 5.83% -46.56% 3.67% 4.88%
Return on Assets (ROA)
2.31% 1.81% 2.60% 0.63% 3.71% 2.35% 1.37% 2.80% -50.05% 0.76% 1.96%
Return on Common Equity (ROCE)
12.44% 8.53% 10.67% 8.49% 13.43% 10.53% 9.62% 10.03% -124.88% 8.42% 8.24%
Return on Equity Simple (ROE_SIMPLE)
0.00% 6.78% 6.52% 4.92% 0.00% 6.68% 5.72% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
163 106 115 96 148 118 121 116 -968 89 76
NOPAT Margin
7.29% 4.42% 4.84% 4.04% 6.05% 4.96% 4.99% 4.68% -37.90% 3.56% 3.08%
Net Nonoperating Expense Percent (NNEP)
2.77% 1.58% 1.44% 2.45% 0.71% 1.01% 1.70% 0.61% 11.62% 1.49% 0.47%
Return On Investment Capital (ROIC_SIMPLE)
1.79% 1.16% - - 1.69% 1.32% 1.32% 1.27% -13.11% 1.18% 1.04%
Cost of Revenue to Revenue
63.11% 64.35% 63.98% 63.80% 64.44% 63.92% 64.91% 65.57% 65.69% 66.02% 66.56%
SG&A Expenses to Revenue
28.80% 29.47% 29.71% 29.78% 29.66% 28.96% 28.95% 28.51% 28.62% 29.24% 29.56%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
28.80% 29.47% 29.71% 29.78% 29.66% 28.96% 28.95% 28.51% 88.46% 29.24% 29.56%
Earnings before Interest and Taxes (EBIT)
148 155 170 107 189 174 127 183 -1,376 104 138
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
307 345 359 290 364 341 299 358 -1,206 266 299
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.48 1.15 0.99 1.18 0.72 0.72 0.84 0.77 0.82 0.72 0.64
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.86 0.60 0.47 0.52 0.30 0.30 0.37 0.34 0.23 0.20 0.17
Price to Earnings (P/E)
19.54 16.95 15.14 23.97 11.60 10.80 14.61 10.52 0.00 0.00 0.00
Dividend Yield
1.22% 1.63% 1.94% 1.61% 2.76% 2.81% 2.32% 2.52% 3.75% 4.22% 4.99%
Earnings Yield
5.12% 5.90% 6.60% 4.17% 8.62% 9.26% 6.84% 9.51% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.23 1.07 0.99 1.08 0.87 0.87 0.92 0.88 0.93 0.90 0.87
Enterprise Value to Revenue (EV/Rev)
1.52 1.21 1.01 1.02 0.77 0.78 0.84 0.80 0.67 0.66 0.61
Enterprise Value to EBITDA (EV/EBITDA)
10.74 8.51 7.09 7.39 5.48 5.57 6.28 5.73 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
17.69 15.54 13.92 16.53 11.93 11.73 13.60 11.59 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
21.20 18.99 17.63 19.47 14.80 14.78 15.76 15.28 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
15.90 18.05 13.84 15.64 11.10 10.48 11.38 10.44 8.14 9.06 8.14
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 9.80 9.57 16.57 14.91 7.85 9.75 5.45
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.19 1.23 1.21 1.18 1.17 1.22 1.14 1.11 1.69 1.70 1.70
Long-Term Debt to Equity
1.19 1.23 1.21 1.18 1.17 1.22 1.14 1.10 1.67 1.43 1.46
Financial Leverage
0.98 0.99 0.97 0.92 1.12 1.15 1.11 1.07 1.30 1.33 1.27
Leverage Ratio
2.80 2.73 2.69 2.92 2.99 2.97 2.93 2.89 3.35 3.31 3.28
Compound Leverage Factor
1.46 1.28 1.38 0.72 1.79 1.72 1.19 1.76 3.52 0.91 1.66
Debt to Total Capital
54.40% 55.12% 54.67% 54.09% 53.96% 54.86% 53.34% 52.64% 62.83% 62.99% 62.93%
Short-Term Debt to Total Capital
0.03% 0.03% 0.02% 0.03% 0.03% 0.01% 0.31% 0.41% 0.89% 9.96% 8.92%
Long-Term Debt to Total Capital
54.37% 55.09% 54.66% 54.06% 53.94% 54.85% 53.03% 52.23% 61.94% 53.03% 54.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
45.60% 44.88% 45.33% 45.91% 46.04% 45.14% 46.66% 47.36% 37.17% 37.01% 37.07%
Debt to EBITDA
4.92 4.50 3.99 3.79 3.50 3.64 3.78 3.55 -22.31 -16.80 -16.25
Net Debt to EBITDA
4.63 4.29 3.82 3.60 3.32 3.41 3.52 3.29 -20.74 -16.01 -15.34
Long-Term Debt to EBITDA
4.92 4.50 3.99 3.79 3.50 3.64 3.76 3.52 -22.00 -14.15 -13.94
Debt to NOPAT
9.72 10.05 9.93 9.98 9.46 9.65 9.49 9.46 -7.22 -7.00 -6.41
Net Debt to NOPAT
9.14 9.58 9.51 9.48 8.98 9.05 8.82 8.77 -6.71 -6.67 -6.06
Long-Term Debt to NOPAT
9.72 10.04 9.92 9.98 9.45 9.65 9.43 9.38 -7.11 -5.89 -5.50
Altman Z-Score
1.24 1.25 1.29 1.39 1.30 1.34 1.33 1.34 0.74 1.15 1.16
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.38 1.56 1.54 1.57 1.42 1.65 1.61 1.56 1.40 1.18 1.18
Quick Ratio
1.05 1.21 1.18 1.20 1.09 1.30 1.22 1.20 1.06 0.88 0.87
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3,853 -3,955 -3,854 -3,974 403 394 96 129 512 1,438 1,903
Operating Cash Flow to CapEx
353.72% -83.61% 396.66% 305.39% 475.02% 2.78% 423.96% 345.56% 546.10% -154.39% 535.33%
Free Cash Flow to Firm to Interest Expense
-54.64 -47.98 -46.74 -49.17 5.30 5.39 1.27 1.79 7.31 19.10 27.95
Operating Cash Flow to Interest Expense
3.25 -0.57 2.89 2.37 3.74 0.02 3.14 3.12 4.92 -1.10 3.79
Operating Cash Flow Less CapEx to Interest Expense
2.33 -1.25 2.16 1.59 2.95 -0.67 2.40 2.22 4.02 -1.82 3.08
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.74 0.84 0.93 0.91 0.79 0.79 0.79 0.79 0.86 0.88 0.87
Accounts Receivable Turnover
4.34 4.76 5.30 5.67 5.04 4.86 4.89 4.88 5.01 4.91 4.94
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
12.35 13.96 15.41 16.51 13.15 13.62 13.38 13.26 13.55 14.18 14.07
Accounts Payable Turnover
22.42 29.23 31.50 34.40 27.22 34.07 30.10 29.06 28.12 36.20 32.36
Days Sales Outstanding (DSO)
84.12 76.63 68.92 64.35 72.39 75.04 74.57 74.86 72.92 74.31 73.91
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
16.28 12.49 11.59 10.61 13.41 10.71 12.12 12.56 12.98 10.08 11.28
Cash Conversion Cycle (CCC)
67.84 64.14 57.34 53.74 58.98 64.33 62.45 62.30 59.93 64.23 62.63
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
8,790 8,904 8,802 8,834 8,535 8,628 8,827 8,822 7,056 7,278 7,000
Invested Capital Turnover
1.05 1.15 1.27 1.38 1.11 1.09 1.09 1.10 1.26 1.25 1.26
Increase / (Decrease) in Invested Capital
4,015 4,061 3,969 4,070 -255 -276 25 -13 -1,479 -1,349 -1,827
Enterprise Value (EV)
10,779 9,516 8,747 9,580 7,409 7,502 8,123 7,803 6,566 6,543 6,055
Market Capitalization
6,132 4,714 4,029 4,915 2,914 2,908 3,575 3,325 2,254 2,020 1,726
Book Value per Share
$62.21 $62.46 $61.88 $63.81 $62.32 $62.64 $66.98 $68.93 $44.08 $45.27 $44.28
Tangible Book Value per Share
($56.16) ($54.85) ($53.14) ($52.02) ($49.90) ($47.56) ($47.11) ($46.44) ($46.38) ($45.05) ($44.29)
Total Capital
9,085 9,138 9,009 9,080 8,775 8,936 9,169 9,172 7,383 7,534 7,286
Total Debt
4,942 5,037 4,925 4,912 4,736 4,902 4,891 4,828 4,639 4,745 4,585
Total Long-Term Debt
4,940 5,034 4,924 4,909 4,733 4,901 4,862 4,790 4,573 3,995 3,935
Net Debt
4,647 4,802 4,718 4,665 4,495 4,594 4,548 4,478 4,311 4,523 4,329
Capital Expenditures (CapEx)
65 56 60 63 60 51 56 65 63 54 48
Debt-free, Cash-free Net Working Capital (DFCFNWC)
492 767 744 795 609 861 883 816 626 993 855
Debt-free Net Working Capital (DFNWC)
787 1,002 951 1,041 849 1,169 1,226 1,166 954 1,216 1,111
Net Working Capital (NWC)
785 999 950 1,038 847 1,168 1,197 1,128 888 466 461
Net Nonoperating Expense (NNE)
93 54 48 80 32 47 79 28 512 67 21
Net Nonoperating Obligations (NNO)
4,647 4,802 4,718 4,665 4,495 4,594 4,548 4,478 4,311 4,490 4,299
Total Depreciation and Amortization (D&A)
160 190 190 183 175 167 172 175 170 162 162
Debt-free, Cash-free Net Working Capital to Revenue
6.91% 9.73% 8.61% 8.45% 6.33% 8.98% 9.17% 8.39% 6.38% 9.98% 8.55%
Debt-free Net Working Capital to Revenue
11.06% 12.71% 11.00% 11.07% 8.83% 12.19% 12.73% 11.99% 9.71% 12.22% 11.11%
Net Working Capital to Revenue
11.03% 12.68% 10.98% 11.04% 8.80% 12.19% 12.44% 11.61% 9.04% 4.68% 4.61%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.02 $0.76 $0.98 $0.25 $1.73 $1.04 $0.63 $1.34 ($23.37) $0.33 $0.86
Adjusted Weighted Average Basic Shares Outstanding
53.80M 65.66M 65.27M 64.66M 64.98M 64.04M 63.36M 62.60M 63.01M 61.28M 60.85M
Adjusted Diluted Earnings per Share
$1.02 $0.76 $0.98 $0.25 $1.72 $1.04 $0.63 $1.34 ($23.37) $0.33 $0.86
Adjusted Weighted Average Diluted Shares Outstanding
54.01M 65.79M 65.33M 64.75M 65.07M 64.07M 63.41M 62.70M 63.01M 61.30M 60.86M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
66.33M 65.99M 65.33M 64.82M 64.40M 63.88M 63.03M 62.26M 61.60M 61.00M 61.02M
Normalized Net Operating Profit after Tax (NOPAT)
163 106 115 96 101 118 121 116 -968 89 76
Normalized NOPAT Margin
7.29% 4.42% 4.84% 4.04% 4.13% 4.96% 4.99% 4.68% -37.90% 3.56% 3.08%
Pre Tax Income Margin
3.46% 3.03% 3.66% 1.11% 4.61% 4.25% 2.14% 4.49% -56.65% 1.15% 2.82%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.09 1.88 2.06 1.33 2.48 2.38 1.69 2.55 -19.68 1.38 2.02
NOPAT to Interest Expense
2.31 1.29 1.40 1.19 1.95 1.61 1.60 1.61 -13.84 1.18 1.12
EBIT Less CapEx to Interest Expense
1.17 1.20 1.33 0.55 1.70 1.69 0.95 1.64 -20.58 0.67 1.31
NOPAT Less CapEx to Interest Expense
1.39 0.61 0.67 0.42 1.16 0.92 0.86 0.71 -14.74 0.47 0.41
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
20.23% 25.10% 28.50% 39.89% 33.36% 31.77% 35.72% 28.16% -7.01% -6.81% -6.95%
Augmented Payout Ratio
40.61% 52.30% 70.34% 100.18% 87.54% 83.84% 94.97% 74.75% -20.20% -20.82% -17.65%

Financials Breakdown Chart

Key Financial Trends

Concentrix (NASDAQ: CNXC) showed a sharp turnaround in Q1 2026 after a very weak Q4 2025, but leverage and cash flow remain the key investor concerns.

For the quarter ended February 28, 2026, Concentrix reported revenue of $2.50 billion, down slightly from $2.55 billion in Q4 2025 and modestly above the prior-year quarter. The more important story was profitability: the company swung from a large loss in Q4 2025 to net income of $21.6 million in Q1 2026. That is an improvement, but earnings remain thin relative to the size of the business.

Operating income also recovered to $118.6 million, compared with an operating loss in the prior quarter. However, interest expense remained heavy at $75.3 million, which continues to absorb a meaningful portion of operating profits. On top of that, Concentrix reported negative operating cash flow of $83.2 million in Q1 2026, despite positive net income. That gap suggests working-capital pressure is still weighing on the business.

The balance sheet shows why investors may remain cautious. Concentrix ended Q1 2026 with $10.7 billion in assets and $7.9 billion in liabilities, including $4.0 billion in long-term debt and $750 million in short-term debt. Cash and equivalents were only $222.7 million, which is not a large cushion relative to debt load and quarterly cash needs.

Looking at the last several years, Concentrix has generally maintained stable revenue in the $2.3 billion to $2.6 billion quarterly range, but margins have been under pressure. Gross profit has been fairly consistent, while operating profit has fluctuated sharply depending on expense levels and acquisition-related impacts. The company also carries a large amount of goodwill and intangible assets, which means future impairments could be a risk if execution weakens.

  • Q1 2026 revenue held near recent levels at $2.50 billion, showing the business remains sizable and relatively stable.
  • The company returned to positive net income in Q1 2026 after a major loss in Q4 2025.
  • Operating income rebounded to $118.6 million from a steep operating loss in the prior quarter.
  • Gross profit stayed healthy at $849.7 million, indicating the core business is still generating solid margin at the top line.
  • Debt was reduced during the quarter through repayments, even though Concentrix also issued debt.
  • Revenue growth over the last four years has been fairly steady, but not particularly strong.
  • EPS improved to $0.33 in Q1 2026, but this is still far below the company’s stronger historical quarters.
  • The balance sheet remains asset-heavy, with substantial goodwill and intangible assets from past acquisitions.
  • Operating cash flow was negative $83.2 million in Q1 2026, which is a major red flag for a company with significant debt.
  • Leverage remains elevated, with about $4.75 billion of total debt outstanding when short-term and long-term debt are combined.

Bottom line: Concentrix has shown it can bounce back from a poor quarter, but the company still looks highly levered and cash-flow challenged. Investors will likely want to see several quarters of stronger operating cash generation before confidence in the turnaround improves.

07/27/26 02:51 AM ETAI Generated. May Contain Errors.

Concentrix Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Concentrix's fiscal year ends in November. Their fiscal year 2025 ended on November 30, 2025.

Concentrix's net income appears to be on a downward trend, with a most recent value of -$1.28 billion in 2025, falling from $117.16 million in 2019. The previous period was $251.22 million in 2024. Find out what analysts predict for Concentrix in the coming months.

Concentrix's total operating income in 2025 was -$918.18 million, based on the following breakdown:
  • Total Gross Profit: $3.44 billion
  • Total Operating Expenses: $4.35 billion

Over the last 6 years, Concentrix's total revenue changed from $4.71 billion in 2019 to $9.83 billion in 2025, a change of 108.7%.

Concentrix's total liabilities were at $8.02 billion at the end of 2025, a 0.8% increase from 2024, and a 178.8% increase since 2020.

In the past 5 years, Concentrix's cash and equivalents has ranged from $145.38 million in 2022 to $327.35 million in 2025, and is currently $327.35 million as of their latest financial filing in 2025.

Over the last 6 years, Concentrix's book value per share changed from 0.00 in 2019 to 44.08 in 2025, a change of 4,408.1%.



Financial statements for NASDAQ:CNXC last updated on 7/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners